Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
26.47
-0.22 (-0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alamar Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 1,805 | - | - |
| Enterprise Value | 1,775 | - | - |
| Debt / Equity Ratio | 0.55 | 0.55 | 0.33 |
| Net Debt / Equity Ratio | 0.15 | 0.15 | -0.45 |
| Net Debt / EBITDA Ratio | -0.40 | -0.40 | 0.98 |
| Net Debt / FCF Ratio | -0.19 | -0.19 | 0.80 |
| Asset Turnover | 0.51 | 0.51 | - |
| Inventory Turnover | 1.23 | 1.23 | - |
| Quick Ratio | 1.80 | 1.80 | 5.23 |
| Current Ratio | 3.99 | 3.99 | 6.43 |
| Return on Equity (ROE) | -33.58% | -33.58% | - |
| Return on Assets (ROA) | -13.53% | -13.53% | - |
| Return on Capital Employed (ROCE) | -27.00% | -27.00% | -37.30% |
| Buyback Yield / Dilution | - | 2.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.